In the fast-paced pharmaceutical and healthcare industries, in-licensing the right product can drive significant growth, while a misstep can drain resources and hinder progress.
At Commercial Eyes, we empower our clients to make informed, confident decisions about whether to license a product by offering comprehensive, data-driven assessments that balance clinical promise with commercial viability.
With a focus on qualitative research, deep industry expertise, and cutting-edge tools like TrialKey, we provide a clear roadmap to evaluate potential assets and determine whether they align with your strategic objectives.
The Importance of a Thorough Assessment
In-licensing decisions can be complex, requiring a nuanced understanding of market dynamics, competitive landscapes, and product differentiation. Key considerations include:
- Market demand: Is there a clearly defined and significant unmet need?
- Competitive positioning: Does the product offer a meaningful advantage over existing therapies?
- Regulatory and market access pathways: Are there barriers to entry in your target markets?
- Commercial viability: Will the product deliver a return on investment within a reasonable timeframe?
At Commercial Eyes, we take a holistic approach to address these questions, ensuring that our clients have the insights they need to make sound decisions.
Qualitative Research: Uncovering the ‘why’ behind the data
While quantitative metrics are critical, qualitative insights often reveal the deeper factors driving market success or failure. Our qualitative research capabilities include:
- Stakeholder perspectives: Understanding the needs, preferences, and decision-making processes of key stakeholders, including clinicians, payers, and patients.
- Market fit analysis: Identifying how well the product aligns with current treatment paradigms and patient pathways.
- Barriers to adoption: Exploring potential challenges, such as clinician resistance, pricing pressures, or access limitations.
These insights provide a contextual layer to complement quantitative analyses, enabling a well-rounded evaluation.
Industry Expertise: Guiding decisions with confidence
With over two decades of experience in healthcare consulting, we combine our knowledge of therapeutic areas, regulatory landscapes, and market access pathways to help clients navigate the complexities of in-licensing.
Key areas of focus include:
- Therapeutic relevance: Evaluating whether the product aligns with current and future treatment trends.
- Regulatory and market access pathways: Tailoring strategies to meet the varied requirements across JAPAC countries.
- Market entry barriers: Identifying and mitigating risks such as pricing pressures, distribution challenges, and competitive dynamics.
- Lifecycle management: Advising on strategies to maximize product value across different phases of development and commercialization.
Our tailored assessments ensure that every recommendation is practical, actionable, and aligned with your broader business objectives.
TrialKey: A game-changer for product assessments
To enhance our evaluations, we integrate TrialKey, an advanced AI-driven platform that provides comprehensive clinical trial insights.
How TrialKey adds value:
- Asset identification: Quickly pinpoint products with strong potential based on clinical trial data.
- Benchmarking: Compare potential assets against competitors in terms of efficacy, safety, and market readiness.
- Unmet need analysis: Highlight areas of opportunity where the product could fill critical gaps in care.
By combining this technological innovation with our qualitative research and industry knowledge, we offer a holistic approach that drives confident decision-making.
Helping you say ‘yes’ or ‘no’ with confidence
Deciding whether to license a product requires balancing potential rewards with inherent risks. At Commercial Eyes, we ensure your decision is based on a thorough, evidence-based evaluation that considers clinical, market, and commercial factors.
Our structured approach includes:
- Comprehensive market assessment: Evaluating demand, competition, and barriers to entry.
- Stakeholder engagement: Understanding the perspectives of clinicians, payers, and patients.
- Regulatory and reimbursement analysis: Assessing the path to market and pricing potential.
Whether the answer is a resounding “yes” or a well-informed “no,” our goal is to give you clarity and confidence in your decision.
Why partner with Commercial Eyes?
At Commercial Eyes, we combine the rigor of advanced analytics, the depth of qualitative research, and the power of industry expertise to guide our clients through the complexities of in-licensing decisions.
With tools like TrialKey and a deep understanding of the JAPAC and global healthcare landscape, we deliver insights that turn uncertainty into opportunity.
Make the right call for your business. Partner with Commercial Eyes to assess your next in-licensing opportunity.
Contact us today to learn how we can help you evaluate and unlock the potential of new products.
Jo Atkins
Head of Access Research and Intelligence
Jo is a registered pharmacist with post graduate qualifications in Health Economics and a Master of Management with a major in Marketing from the Macquarie Graduate School of Management...
View Profile